AstraZeneca (United States)
About
In recent decades, authors affiliated with AstraZeneca (United States) have published 6.2k papers, which have received a total of 190.9k indexed citations.
Scholars at this organization have produced 1.5k papers in Molecular Biology, 1.5k papers in Pulmonary and Respiratory Medicine and 1.4k papers in Oncology on the topics of Asthma and respiratory diseases (493 papers), Lung Cancer Treatments and Mutations (446 papers) and Diabetes Treatment and Management (398 papers). Their work is cited by papers focused on Molecular Biology (51.2k citations), Oncology (40.5k citations) and Pulmonary and Respiratory Medicine (37.8k citations). Authors at AstraZeneca (United States) collaborate with scholars in United States, United Kingdom and Sweden and have published in prestigious journals including Nature, Science and Cell. Some of AstraZeneca (United States)'s most productive authors include Robert F. Storey, Eric L. Michelson, Nicholas J. Brandon, Wright W. Nichols and J. Carl Barrett.
In The Last Decade
Fields of papers published by authors at AstraZeneca (United States)
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
This network shows the specialization of papers affiliated with AstraZeneca (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.
Countries citing scholars working at AstraZeneca (United States)
Since SpecializationCitations
This map shows the geographic impact of research produced by authors working at AstraZeneca (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AstraZeneca (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AstraZeneca (United States) more than expected).
Explore institutions with similar magnitude of impact
Breakdown of academic impact, for scholars at Institut des Sciences Chimiques de Rennes Breakdown of academic impact, for scholars at Observatoire de Paris Breakdown of academic impact, for scholars at IRCCS Ospedale San Raffaele Breakdown of academic impact, for scholars at Institute for Molecular Science Breakdown of academic impact, for scholars at Emory University Hospital Breakdown of academic impact, for scholars at Centre Hospitalier de l’Université de Montréal Breakdown of academic impact, for scholars at Northwestern Memorial Hospital Breakdown of academic impact, for scholars at National Institute of Health Sciences